BR112014003582A2 - inibidores da tirosina quinase de bruton - Google Patents

inibidores da tirosina quinase de bruton

Info

Publication number
BR112014003582A2
BR112014003582A2 BR112014003582A BR112014003582A BR112014003582A2 BR 112014003582 A2 BR112014003582 A2 BR 112014003582A2 BR 112014003582 A BR112014003582 A BR 112014003582A BR 112014003582 A BR112014003582 A BR 112014003582A BR 112014003582 A2 BR112014003582 A2 BR 112014003582A2
Authority
BR
Brazil
Prior art keywords
compounds
tyrosine kinase
kinase inhibitors
bruton tyrosine
context
Prior art date
Application number
BR112014003582A
Other languages
English (en)
Inventor
Brotherton-Pleiss Christine
Javier Lopez-Tapia Francisco
Jaime-Figueroa Saul
d owens Timothy
Lou Yan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46690498&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112014003582(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112014003582A2 publication Critical patent/BR112014003582A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Abstract

resumo inibidores da tirosina quinase de bruton o presente pedido expõe compostos de acordo com a fórmula i genérica: y2nonhrayy1nxoy4y3ohi em que as variáveis são definidas da forma descrita neste 5 contexto, e que inibem a btk. os compostos expostos neste contexto são de utilidade para modularem a atividade da btk e tratar as enfermidades associadas com a atividade excessiva da btk. os compostos são ainda de utilidade para tratarem enfermidades inflamatórias e auto-imunes 10 associadas com a proliferação de células b aberrantes (anormais), tais como artrite reumatóide. igualmente associados estão as composições que contêm os compostos da fórmula i e pelo menos um veículo, diluente ou excipiente. 15
BR112014003582A 2011-08-17 2012-08-14 inibidores da tirosina quinase de bruton BR112014003582A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161524374P 2011-08-17 2011-08-17
US201261649991P 2012-05-22 2012-05-22
PCT/EP2012/065844 WO2013024078A1 (en) 2011-08-17 2012-08-14 Inhibitors of bruton's tyrosine kinase

Publications (1)

Publication Number Publication Date
BR112014003582A2 true BR112014003582A2 (pt) 2017-03-14

Family

ID=46690498

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014003582A BR112014003582A2 (pt) 2011-08-17 2012-08-14 inibidores da tirosina quinase de bruton

Country Status (22)

Country Link
US (1) US8889682B2 (pt)
EP (1) EP2744804B1 (pt)
JP (1) JP5823616B2 (pt)
KR (1) KR20140052032A (pt)
CN (1) CN103748088A (pt)
AR (1) AR087543A1 (pt)
AU (1) AU2012296888A1 (pt)
BR (1) BR112014003582A2 (pt)
CA (1) CA2841801A1 (pt)
CL (1) CL2014000350A1 (pt)
CO (1) CO6842020A2 (pt)
CR (1) CR20140027A (pt)
EA (1) EA024689B1 (pt)
EC (1) ECSP14013212A (pt)
HK (1) HK1197060A1 (pt)
IL (1) IL230561A0 (pt)
MA (1) MA35419B1 (pt)
MX (1) MX349372B (pt)
PE (1) PE20140865A1 (pt)
TW (1) TW201311669A (pt)
WO (1) WO2013024078A1 (pt)
ZA (1) ZA201400739B (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2552514T3 (es) 2011-11-03 2015-11-30 Hoffmann-La Roche Ag Compuestos bicíclicos de piperazina
WO2013067264A1 (en) 2011-11-03 2013-05-10 Genentech, Inc. 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
UA111756C2 (uk) 2011-11-03 2016-06-10 Ф. Хоффманн-Ля Рош Аг Сполуки гетероарилпіридону та азапіридону як інгібітори тирозинкінази брутона
BR112014010439A2 (pt) 2011-11-03 2017-04-18 F Hoffmann - La Roche Ag compostos, composição farmacêutica, processo de produção, método de tratamento de uma doença ou distúrbio, métodos, kit e uso de uma composição farmacêutica
CN104662018B (zh) 2012-04-20 2017-10-24 阿迪维纳斯治疗有限公司 取代的杂双环化合物、组合物及其医疗应用
WO2013157021A1 (en) 2012-04-20 2013-10-24 Advinus Therapeutics Limited Bicyclic compounds, compositions and medicinal applications thereof
CN104704129A (zh) 2012-07-24 2015-06-10 药品循环公司 与对布鲁顿酪氨酸激酶(btk)抑制剂的抗性相关的突变
WO2014025976A1 (en) 2012-08-10 2014-02-13 Boehringer Ingelheim International Gmbh Heteroaromatic compounds as bruton's tyrosine kinase (btk) inhibitors
JP6088063B2 (ja) * 2012-11-16 2017-03-01 エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ ブルトン型チロシンキナーゼの阻害剤
MX2015006457A (es) * 2012-11-30 2015-08-14 Hoffmann La Roche Inhibidores de la tirosina cinasa de bruton.
EP2964627B1 (en) 2013-03-05 2017-03-01 F. Hoffmann-La Roche AG Inhibitors of bruton's tyrosine kinase
CN104177338B (zh) * 2013-05-22 2018-04-03 南京勇山生物科技有限公司 一类布鲁顿激酶抑制剂
CA2912359A1 (en) * 2013-07-03 2015-01-08 F. Hoffmann-La Roche Ag Heteroaryl pyridone and aza-pyridone amide compounds
CA2919068C (en) 2013-07-26 2018-03-20 Carna Biosciences, Inc. Triazine derivative
EP3048102A1 (en) * 2013-09-20 2016-07-27 Carna Biosciences Inc. Novel triazine derivative
KR101813830B1 (ko) 2013-12-05 2017-12-29 에프. 호프만-라 로슈 아게 친전자성 작용기를 갖는 헤테로아릴 피리돈 및 아자-피리돈 화합물
EP3042903B1 (en) 2015-01-06 2019-08-14 Impetis Biosciences Ltd. Substituted hetero-bicyclic compounds, compositions and medicinal applications thereof
DK3247699T3 (da) 2015-01-22 2019-08-12 Sanofi Aventis Deutschland Proces til produktion of 2-[4-(cyclopropancarbonyl)phenyl]-2-methyl-propannitril
US10208024B2 (en) 2015-10-23 2019-02-19 Array Biopharma Inc. 2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases
AU2021267373A1 (en) 2020-05-06 2022-12-08 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
WO2023009709A1 (en) * 2021-07-29 2023-02-02 Ajax Therapeutics, Inc. Pyrazolo piperazines as jak2 inhibitors
WO2023086319A1 (en) 2021-11-09 2023-05-19 Ajax Therapeutics, Inc. 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
CN115073299A (zh) * 2022-06-14 2022-09-20 爱斯特（成都）生物制药股份有限公司 一种制备2-氟-3-三氟甲基苯胺的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7683064B2 (en) * 2008-02-05 2010-03-23 Roche Palo Alto Llc Inhibitors of Bruton's tyrosine kinase
WO2009098144A1 (en) * 2008-02-05 2009-08-13 F. Hoffmann-La Roche Ag Novel pyridinones and pyridazinones
EP2297142B1 (en) 2008-06-24 2015-10-14 F. Hoffmann-La Roche AG Novel substituted pyridin-2-ones and pyridazin-3-ones
US8299077B2 (en) * 2009-03-02 2012-10-30 Roche Palo Alto Llc Inhibitors of Bruton's tyrosine kinase
AR082590A1 (es) * 2010-08-12 2012-12-19 Hoffmann La Roche Inhibidores de la tirosina-quinasa de bruton
WO2013067264A1 (en) * 2011-11-03 2013-05-10 Genentech, Inc. 8-fluorophthalazin-1 (2h) - one compounds as inhibitors of btk activity
CA2853138A1 (en) * 2011-12-05 2013-06-13 Immunomedics, Inc. Therapeutic use of anti-cd22 antibodies for inducing trogocytosis

Also Published As

Publication number Publication date
ECSP14013212A (es) 2014-03-31
CA2841801A1 (en) 2013-02-21
EP2744804A1 (en) 2014-06-25
CN103748088A (zh) 2014-04-23
CO6842020A2 (es) 2014-01-20
AU2012296888A1 (en) 2014-01-23
JP5823616B2 (ja) 2015-11-25
AR087543A1 (es) 2014-04-03
US8889682B2 (en) 2014-11-18
HK1197060A1 (en) 2015-01-02
ZA201400739B (en) 2016-01-27
IL230561A0 (en) 2014-03-31
EA024689B1 (ru) 2016-10-31
PE20140865A1 (es) 2014-07-19
WO2013024078A1 (en) 2013-02-21
US20130045965A1 (en) 2013-02-21
JP2014521734A (ja) 2014-08-28
CL2014000350A1 (es) 2014-08-22
KR20140052032A (ko) 2014-05-02
MX2014001653A (es) 2014-03-21
EA201490452A1 (ru) 2014-05-30
CR20140027A (es) 2014-03-13
TW201311669A (zh) 2013-03-16
MA35419B1 (fr) 2014-09-01
MX349372B (es) 2017-07-26
EP2744804B1 (en) 2017-05-17

Similar Documents

Publication Publication Date Title
BR112014003582A2 (pt) inibidores da tirosina quinase de bruton
BR112015010693A2 (pt) inibidores de tirosina quinase de bruton
BR112014013582A2 (pt) inibidores de quinase de tirosina de bruton
BR112015007513A2 (pt) inibidores de tirosina quinase de bruton
BR112012024117A2 (pt) inibidores de pirrolopirazina quinase
BR112013003114A2 (pt) inibidores de tirosina quinase de bruton
BR112015021677A2 (pt) inibidores de tirosina quinase de bruton
MX345170B (es) Inhibidores de la tirosina-cinasa de bruton.
BR112015021806A2 (pt) inibidores de tirosina cinase de bruton
MX2014002442A (es) Inhibidores de pirrolopirazina cinasa.
ATE517107T1 (de) Pyrrolopyrazinkinaseinhibitoren
BR112016014412A2 (pt) Compostos de diaminopirimidil substituído, composições do mesmo, e métodos de tratamento com o mesmo
DK2250172T3 (da) Pyrrolopyrazinkinaseinhibitorer
BR112013000107A2 (pt) aminopirazoloquinazolinas
BR112012010186A2 (pt) derivados de heteroarila contendo n como inibidores de quinase jak3.
BR112013021896A2 (pt) inibidores de serina/treonina cinase
BR112013004517A2 (pt) derivados de triazolopirazina
BR112014002675A2 (pt) "quinazolina como inibidores de serina/treonina quinase, seus usos, e composição"
DOP2014000012A (es) Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa
BR112012023752A2 (pt) derivados de pirrolopirazina e seu uso como inibidores de jak e syk
BR112018012981A2 (pt) derivados do ácido meta-azacíclico amino benzoico como antagonistas de pan integrina com melhores propriedades farmacocinéticas
EA201790206A1 (ru) Новые 2,5-замещенные пиримидины в качестве ингибиторов pde4
EA201400831A1 (ru) Пиразолопиримидиниловые ингибиторы убиквитин-активирующего фермента
MX2016006763A (es) Inhibidores de tirosina cinasa de bruton.
MX2016000547A (es) Nuevos derivados de azabencimidazol.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2527 DE 11-06-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.